Tervisetehnoloogiate Arenduskeskus AS (The Competence Centre on Health Technologies, CCHT) is a biotechnology company established in 2009, that during 2009-2014 was known as the Competence Centre on Reproductive Medicine and Biology (CCRMB). Until 2014, the research in CCHT was focused on novel approaches for human infertility diagnostics and treatment, and human and animal assisted reproductive technologies. CCRMB was founded as a consortium consisting of academia, leading biotechnology enterprises and human/veterinary clinics in Estonia (in total 13 partners). The aim of CCRMB is through collaboration to create synergy between all partners in order to establish a platform for new opportunities to develop innovative technologies as well as to boost commercialization of scientific achievements.
In 2014, CCHT long-term development plan was renewed. As a result, personalised medicine and drug development were added as new development areas starting from 2015 as well as a new name for company - Tervisetehnoloogiate Arenduskeskus AS (The Competence Centre on Health Technologies, CCHT) was introduced.
Scientific Advisory Board
Prof. Aleksander Giwercman (Lundi Ülikool, Malmö, Rootsi)
Prof. Zygmunt Gryczynski (Põhja-Texase Ülikool, Texas, USA)
Prof. Daniela Toniolo (San Raffaele Teadusinstituut, Milano, Itaalia)
Prof. Gilbert Charles Antoine Faure (Henri Poincaré Ülikool, Nancy, Prantsusmaa)
Prof. Outi Hovatta (Karolinska Instituut, Stockholm, Rootsi)
Prof. Tore Midtvedt (Karolinska Instituut, Stockholm, Rootsi)